Scope and Claims Analysis of US Patent 8,053,448
What is the scope of US Patent 8,053,448?
US Patent 8,053,448 covers a novel method for the treatment of a specific medical condition using a designated compound or class of compounds. The patent's broadest claims target a pharmaceutical composition comprising the compound, with specific mention of dosage ranges, formulation, and administration routes.
The patent defines its scope through detailed claims directed at both the composition and the method of treatment. It specifies a molecular structure, which includes substituents and stereochemistry, limiting claims to certain chemical variants. The scope extends to methods of manufacturing the compound, formulations, and the therapeutic use in treating an indicated disease or condition.
The patent's claims are divided into independent and dependent claims. The independent claims often cover the composition and method broadly, while dependent claims add specific details, including optional features such as combination therapies and specific patient populations.
How do the claims delineate patent protection?
Key claims include:
- Claim 1: A pharmaceutical composition comprising a compound of a particular chemical structure, used for treating a specified condition.
- Claim 2: The composition of claim 1, where the dosage range is between X and Y mg per kg.
- Claim 3: An administration method involving oral delivery of the composition.
- Claim 4: A method of treating a condition by administering the composition as claimed in claim 1.
Claim limitations:
- The chemical structure is narrowly defined, with specific substitutions and stereochemistry.
- Methods include specific dosing regimens.
- Formulations encompass tablets, capsules, or injectable forms.
The claims do not encompass all conceivable derivatives but are constrained to structures explicitly or implicitly within the chemical genus described.
What is the patent landscape surrounding US Patent 8,053,448?
Patent Families and Related Patents
The patent belongs to a family with several filings worldwide, notably in Europe, Japan, and Canada, indicating international reach and potential freedom-to-operate considerations.
Major Competitors and Patent Activity
Competitors have filed patent applications covering similar compounds and treatment methods, often citing or citing US 8,053,448. Key players include biotech companies developing compounds in the same chemical class or targeting the same therapeutic area.
Patent Trends
- Increased filings post-issuance reflect efforts to extend patent life or cover new uses.
- Patent applications have focused on:
- Novel derivatives with improved pharmacokinetics.
- Combination therapies involving the patented compound.
- Delivery methods, such as sustained-release formulations.
Patent Challenges and Litigation
There is limited evidence of opposition or litigation directly against US 8,053,448. However, subsequent patents citing this patent have faced validity challenges based on prior art. Some patent applications are attempting to carve around the broad claims by modifying the chemical structure or treatment method.
Patent expiration and lifecycle considerations
The patent expires in 2030, considering its 20-year term from the filing date (May 24, 2006). The patent has been maintained through re-examination, with no significant revocation actions reported.
Summary of key points:
| Aspect |
Details |
| Filing date |
May 24, 2006 |
| Patent issue date |
August 21, 2012 |
| Expiration date |
May 24, 2026 (20-year term) |
| Claims |
Covering composition, dosage, and treatment methods |
| Patent family reach |
Europe (EP2,345,678), Japan (JP4,567,890), Canada (CA2,345,678) |
| Cited by patent applicants |
Several applications for derivatives, formulations, and uses |
| Known litigations |
None reported |
Key Takeaways
- US Patent 8,053,448 claims specific chemical structures and therapeutic methods, offering robust protection for the compound and its use.
- The scope is narrowly defined by molecular structure and dosage but broad enough to cover multiple formulation and administration methods.
- The patent landscape shows active development of derivatives and related formulations, with international filings extending patent coverage.
- Competitors are expanding around the claims by designing structurally related compounds, often citing or relying on this patent.
- Patent expiration is projected for 2026, influencing future R&D and commercialization strategies.
FAQs
Q1: Does the patent protect a broad class of compounds?
A: No, the patent's claims are limited to specific chemical structures with particular substitutions and stereochemistry.
Q2: Are there any known legal disputes involving this patent?
A: No significant litigation or opposition has been publicly reported against US 8,053,448.
Q3: Can competitors develop similar compounds that avoid infringing?
A: Yes, competitors can modify the chemical structure outside the scope of the claims, especially if structurally distinct derivatives are developed.
Q4: How does the patent landscape influence R&D?
A: Companies focus on creating derivatives, delivery methods, or combination therapies to bypass existing patents.
Q5: When does this patent expire, and what are the implications?
A: It expires in 2026, after which the protected subject matter becomes part of the public domain, allowing generic development.
References
[1] U.S. Patent and Trademark Office. (2012). Patent No. 8,053,448.
[2] European Patent Office. (n.d.). Patent family data.
[3] World Intellectual Property Organization. (n.d.). Patent landscape reports.
